Health Care
Companies operating within the Health Care industry, ranked by market capitalization.
| Ticker | Exchange | Company Name | Last Price | % Change | Volume | Market Cap |
|---|---|---|---|---|---|---|
| RAPP | NASDAQ | Rapport Therapeutics | $33.12 | +0.36% | 256K | $1.57B |
| PRGO | NYSE | Perrigo Company plc | $11.72 | +3.76% | 2M | $1.55B |
| INSP | NYSE | Inspire Medical Systems | $54.35 | +1.76% | 787K | $1.55B |
| ATAI | NASDAQ | ATAI Life Sciences N.V. | $4.05 | -1.70% | 5M | $1.5B |
| NUVB | NYSE | Nuvation Bio | $4.44 | +2.19% | 4M | $1.49B |
| HROW | NASDAQ | Harrow | $39.98 | -0.66% | 522K | $1.49B |
| CAPR | NASDAQ | Capricor Therapeutics | $33.91 | +4.47% | 867K | $1.48B |
| OCS | NASDAQ | Oculis Holding AG | $27.06 | +2.31% | 349K | $1.48B |
| ARDX | NASDAQ | Ardelyx | $6.38 | +6.07% | 2M | $1.46B |
| PGEN | NASDAQ | Precigen | $4.20 | +1.94% | 3M | $1.46B |
| PVLA | NASDAQ | Palvella Therapeutics | $127.00 | +3.72% | 186K | $1.45B |
| NTLA | NASDAQ | Intellia Therapeutics | $13.71 | +10.12% | 17M | $1.44B |
| UFPT | NASDAQ | UFP Technologies | $190.73 | +2.85% | 239K | $1.43B |
| IMCR | NASDAQ | Immunocore Holdings plc | $27.94 | +0.07% | 364K | $1.41B |
| VIR | NASDAQ | Vir Biotechnology | $10.33 | +2.43% | 1M | $1.4B |
| ATEC | NASDAQ | Alphatec Holdings | $9.68 | +4.09% | 3M | $1.38B |
| ARDT | NYSE | Ardent Health Partners | $9.45 | -1.87% | 323K | $1.38B |
| MPLT | NASDAQ | MapLight Therapeutics | $31.73 | +4.75% | 407K | $1.37B |
| PLSE | NASDAQ | Pulse Biosciences | $20.72 | +2.50% | 253K | $1.37B |
| AVAH | NASDAQ | Aveanna Healthcare Holdings | $6.52 | -0.53% | 1M | $1.37B |
| IMTX | NASDAQ | Immatics N.V | $11.23 | +0.27% | 292K | $1.36B |
| ATRC | NASDAQ | Atricure | $27.79 | +1.65% | 752K | $1.36B |
| KALV | NASDAQ | KalVista Pharmaceuticals | $26.68 | +0.04% | 15M | $1.35B |
| NVCR | NASDAQ | NovoCure | $15.31 | +28.33% | 1M | $1.34B |
| CLOV | NASDAQ | Clover Health Investments | $2.68 | +3.68% | 5M | $1.33B |
| WVE | NASDAQ | Wave Life Sciences | $7.13 | +1.13% | 4M | $1.33B |
| IOVA | NASDAQ | Iovance Biotherapeutics | $3.40 | +2.72% | 12M | $1.31B |
| NVAX | NASDAQ | Novavax | $8.14 | +2.07% | 3M | $1.3B |
| ENOV | NYSE | Enovis | $22.87 | +1.69% | 906K | $1.29B |
| MBX | NASDAQ | MBX Biosciences | $29.47 | +3.01% | 513K | $1.28B |
| VRDN | NASDAQ | Viridian Therapeutics | $13.41 | +0.83% | 2M | $1.27B |
| STAA | NASDAQ | Staar Surgical Company | $26.16 | +2.65% | 744K | $1.27B |
| BFLY | NYSE | Butterfly Network | $4.78 | -2.85% | 6M | $1.24B |
| AVBP | NASDAQ | ArriVent BioPharma | $30.65 | +2.00% | 550K | $1.24B |
| MAZE | NASDAQ | Maze Therapeutics | $26.38 | +2.73% | 549K | $1.24B |
| AHG | NASDAQ | Akso Health Group | $2.25 | +0.22% | 184K | $1.23B |
| TNDM | NASDAQ | Tandem Diabetes Care | $19.25 | +6.00% | 2M | $1.23B |
| GLUE | NASDAQ | Monte Rosa Therapeutics | $19.01 | +1.52% | 656K | $1.22B |
| PRCT | NASDAQ | Procept BioRobotics | $24.86 | +14.51% | 1M | $1.21B |
| EXE.TO | TSX | Extendicare Inc | $29.81 | -1.12% | 226K | $1.21B |
| CALT | – | Calliditas Therapeutics AB | $0.00 | 0.00% | 0 | $1.19B |
| GHRS | NASDAQ | GH Research PLC | $19.72 | +2.92% | 244K | $1.19B |
| BCAX | NASDAQ | Bicara Therapeutics | $21.60 | +1.50% | 355K | $1.17B |
| NEO | NASDAQ | Neogenomics | $9.12 | +1.79% | 4M | $1.16B |
| AVNS | NYSE | Avanos Medical | $24.65 | -0.02% | 1M | $1.14B |
| ABCL | NASDAQ | AbCellera Biologics | $4.12 | +7.72% | 11M | $1.14B |
| KMTS | NASDAQ | Kestra Medical Technologies | $20.01 | +2.56% | 204K | $1.14B |
| CNMD | NYSE | Conmed | $35.77 | -0.53% | 407K | $1.11B |
| PHAR | NYSE EURONEXT - EURONEXT AMSTERDAM | Pharming Group N.V. | $16.67 | +1.90% | 6K | $1.11B |
| INNV | NASDAQ | InnovAge Holding | $8.09 | +0.19% | 195K | $1.09B |